Member Info for dan1nat1

Strange that Mani still posts here, I wonder if it’s a service she offers on all her ex holdings?

Maybe she is still bitter about her loss?

Or maybe she chose a low volume day to try to rattle a few holders into selling so she can buy back in...

Did we ever get to see that “Twitter rumour”?

Look at the date of that Tweet.

You are getting a bargain compared to what most people paid...including some big ii's.

L2 looking strong 4p offer wont last long...

When the "new platform" RNS lands we could really see the herd arrive!

There was some big buying on Friday, potentially they have closed or are at least starting to.

Potential big news could land anytime if the mobile rumours are true...

3.7p incoming on the bid judging by L2 during the auction.

There are a number of sites down according to Twitter reports.

It would but I expect that will only happen when it’s a done deal, at which point stand well back from the sell button and watch the show ;)

That was an LSE glitch, showing the last trade twice as it has on all my holdings.

It was a buy imo.

5m bang on the mid looks interesting...

None that I have seen, its generally pretty quiet on Twitter Re FARN.

Nice to get some consolidation at this level, especially as the next leg up will hopefully be due to a juicy RNS.

MM's are still offering over @ 101 but only on 25k shares, I would not rule out a late flurry of buying sending us back to level for the day.

Monday might be to soon...lets give them until Tuesday at least ;)

Agreed it does not look like we are presenting, but this event has specifically been mentioned in the last interview as being when a number of meetings are arranged for.

Latest interview -

https://www.proactiveinvestors.co.uk/companies/stocktube/13238/faron-pharma-updates-on-clevegen-development-as-partner-discussions-advance-13238.html

Kev,

Totally agree, opening up all subgroups will be fantastic news. But if we come to market initially with just the sub group at least we will have funds coming in and a foothold in the market place.

In the latest interview Markku mentions waiting for regulator advise on the next Traumakine trial, and makes no mention of it being just the sub group I hope this means early YODA feedback is as expected, he certainly seems confident about its future.

Starts today!

https://meetings.asco.org/am/attend-meeting

We could see some significant news flow in the coming weeks.

It is a valid point Kev, of the 3 Cyno has listed which is closest to a P3? Have any of them reported to actually work or are they all still at dose escalation?

The last one posted doesn’t seem to have had any updates in over a year, so I’m assuming we can not worry about that one just yet.

I’m not sure finding customers is the problem, but if it were with our cost base +5% would still see us at the cheaper end of the market.